Why is Solara Active falling/rising?

As of 23-Sep, Solara Active Pharma Sciences Ltd is currently priced at 655.60, reflecting a decrease of 4.85 points or 0.73%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 4.68% during this period. Additionally, the stock's performance over the past week shows a decline of 3.20%, while it has outperformed the benchmark Sensex over the past month with a gain of 4.06%. Despite positive financial results, including a 16.9% growth in net sales and consistent profitability over the last four quarters, the stock's current price movement indicates a lack of investor confidence, as evidenced by a 12.7% drop in delivery volume compared to the five-day average.
Broader market context reveals that while the stock has struggled year-to-date with a decline of 3.01%, the Sensex has gained 5.07% in the same timeframe. This underperformance is further highlighted by the stock's one-year return of -16.20%, contrasting sharply with the Sensex's decline of only 3.33%. The stock's attractive valuation, indicated by a PEG ratio of 0.9 and a trading discount compared to peers, suggests potential for recovery; however, the recent negative momentum and falling investor participation are significant factors contributing to its current decline.